Lyka Labs share news, announcements and annual reports
NSE: LYKALABSBSE: 500259Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 2 Nov 2026. Previous close ₹76.60.
2 Nov: open ₹76.00, high ₹76.00, low ₹75.07
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹271 Cr2,310th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.83
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −4.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.47
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 15,895
Lyka Labs share news and announcements
1,493 announcements, routine notices left out, newest first. Page 7 of 30.
Jan 2024
18 Jan · Notice Of The Meeting Of The Secured Creditors To Be Held As Per The Order Of The Hon'Ble National Company Law Tribunal.
18 Jan · Notice Of The Meeting Of The Preference Shareholders To Be Held As Per The Order Of The Hon'Ble National Company Law Tribunal.
18 Jan · Notice Of The Meeting Of The Equity Shareholders To Be Held As Per The Order Of The Hon'Ble National Company Law Tribunal.
16 Jan · Updates
16 Jan · Convening The Meetings Of The Shareholders And Creditors, As Per The Order Of The Hon'ble National Company Law Tribunal
16 Jan · Management
Dec 2023
19 Dec · Rating
Nov 2023
25 Nov · Business
2 Nov · Results
2 Nov · Board meeting
2 Nov · Board meeting
Oct 2023
10 Oct · Receipt Of Product Permission From Central Drugs Standard Control Organization Of India For Tofacitinib Ointment 2% W/W.
Sep 2023
Aug 2023
2 Aug · Results
2 Aug · Board meeting
2 Aug · Board meeting
Jul 2023
17 Jul · Meeting
17 Jul · Updates
14 Jul · Corporate action